Metraipolis › archive › dc_24d7fe53e153

Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential… — Europe PMC PMID:41599651

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41599651
DOI
10.3390/ph19010050
License (as archived)
solo-consultazione
Archived
2026-11-07T10:11:34.910Z
SHA-256 of the archived text
cc173acc50d67eb4b8b758809b84a926d1ecef562f6707f993501d8ac86c1e38
Stable URL of this page
https://metraipolis.com/documento/dc_24d7fe53e153

How to cite

Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential… — Europe PMC PMID:41599651 — Europe PMC (en), https://europepmc.org/article/MED/41599651 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_24d7fe53e153 (Metraipolis archive dc_24d7fe53e153, sha256 cc173acc50d67eb4b8b758809b84a926d1ecef562f6707f993501d8ac86c1e38)
BibTeX
@misc{dc24d7fe53e153,
  title = {Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential… — Europe PMC PMID:41599651},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41599651},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_24d7fe53e153; sha256 cc173acc50d67eb4b8b758809b84a926d1ecef562f6707f993501d8ac86c1e38},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41599651. Agents can read the archived copy with the MCP tool read_document.